A New Treatment For Alpha-Mannosidosis Just Got Authorized By The EMA
source: pixabay.com

A New Treatment For Alpha-Mannosidosis Just Got Authorized By The EMA

According to an announcement from ema.europa.eu, the European Medicines Agency (EMA) recently granted market authorization for a new treatment for alpha-mannosidosis. The new drug is an enzyme replacement therapy called…

Continue Reading A New Treatment For Alpha-Mannosidosis Just Got Authorized By The EMA
The Orphan Disease Center Just Announced Their 2018 Grant For CDKL5 Deficiency Disorder
source: pixabay.com

The Orphan Disease Center Just Announced Their 2018 Grant For CDKL5 Deficiency Disorder

The Orphan Disease Center in association with the University of Pennsylvania and the Loulou Foundation just announced their 2018 Pilot Grant Program for CDKL5 Deficiency Disorder. CDKL5 deficiency disorder (CDD)…

Continue Reading The Orphan Disease Center Just Announced Their 2018 Grant For CDKL5 Deficiency Disorder
NHS Inefficiency and Possible Funding Cuts Are Depriving Multiple Sclerosis Patients of Timely Care
source: pixabay.com

NHS Inefficiency and Possible Funding Cuts Are Depriving Multiple Sclerosis Patients of Timely Care

According to a story from Independent, cumbersome delays and possible funding cuts are severely hampering England's National Health Service (NHS). These delays are proving very costly for patients with long…

Continue Reading NHS Inefficiency and Possible Funding Cuts Are Depriving Multiple Sclerosis Patients of Timely Care
Reporter Fundraises For Progressive Supranuclear Palsy Research
https://pixabay.com/en/news-information-announcement-1980105/

Reporter Fundraises For Progressive Supranuclear Palsy Research

Adam Murphy, a reporter for CBS46 learned of his mother's diagnosis of Progressive Supranuclear Palsy, PSP, in 2010 and decided to use his reporter platform to help her, originally reported…

Continue Reading Reporter Fundraises For Progressive Supranuclear Palsy Research